Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait
Yanwei Cai, Nora Franceschini, Aditya Surapaneni, Melanie E. Garrett, Usman A. Tahir, Li Hsu, Marilyn J. Telen, Bing Yu, Hua Tang, Yun Li, Simin Liu, Robert E. Gerszten, Josef Coresh, JoAnn E. Manson, Genevieve L. Wojcik, Charles Kooperberg, Paul L. Auer, Matthew W. Foster, Morgan E. Grams, Allison E. Ashley-Koch, Laura M. Raffield, Alex P. Reiner- Transplantation
- Nephrology
- Critical Care and Intensive Care Medicine
- Epidemiology
Background
Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
Methods
We measured proteomics (
Results
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait–protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait–associated proteins are known biomarkers of kidney function or injury (
Conclusions
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.